Pre-IPO Investing in Australia: What You Need to Know

The most valuable technology companies in the world are private. SpaceX, OpenAI, Anthropic, Anduril, Databricks, Stripe. Between them, trillions of dollars in enterprise value. Some of the most consequential businesses of the next decade. And none of them trade on a public exchange.

This has been building for years. Companies are staying private for longer, raising enormous sums from venture capital and sovereign wealth funds, and deferring IPOs well past the point where their predecessors would have listed. The median company now goes public 14 years after founding, up from five years two decades ago. The number of unicorns (private companies valued above US$1 billion) has swelled past 1,200 globally. And the pool of publicly listed companies in the US has actually been shrinking.

For Australian investors, this creates a practical problem. If you restrict yourself to ASX-listed equities and publicly traded US stocks, you're accessing a shrinking slice of where global value creation is actually happening. Pre-IPO investing solves that problem, but it requires understanding the structures, the eligibility requirements, and the risks involved.

This guide covers all of it.

The structural case for pre-IPO access

A decade ago, you could reasonably argue that buying companies at IPO was early enough. The data no longer supports that.

Andreessen Horowitz published research showing that companies which went public between 2014 and 2019 generated more than 80% of their total market capitalisation after listing. For more recent IPO cohorts, that ratio has flipped. The majority of value creation now happens while companies are still private, and public market investors are arriving later in the growth curve than at any point in modern market history.

Renaissance Capital's data tells the same story from a different angle. In 2018, the median age of a company at IPO was 10 years. By 2025, it had climbed to 13. Companies are also listing with significantly more revenue. Median IPO revenue has grown from US$64 million (inflation-adjusted) in 1980 to US$218 million by 2024.

SpaceX was founded in 2002 and is only now, 24 years later, preparing for a potential IPO at up to US$1.75 trillion. OpenAI was founded in 2015 and sits at an US$852 billion private valuation. Anthropic, founded in 2021, has already crossed US$60 billion.

These are not edge cases. They represent what the private markets look like now. And the investors who have benefited most from their growth are the ones who got access before the IPO window opened.

How Australian investors access pre-IPO companies

There are several pathways, each with meaningfully different structures and trade-offs.

Direct access through a private markets platform

Platforms like NonPublic source shares from existing shareholders of private companies and structure them into SPVs (special purpose vehicles) that qualified Australian investors can participate in. The shares typically come from early employees, venture investors, or institutional holders looking for liquidity ahead of a listing.

You choose the company. You know what you own. There's no portfolio of 500 other holdings diluting your thesis. If you have conviction in a specific business, this is the cleanest way to express it.

The trade-off is illiquidity. Your capital stays locked until a liquidity event like an IPO, acquisition, or secondary sale. Minimum ticket sizes tend to be higher than buying units in a listed fund. And you need to qualify as a wholesale or sophisticated investor under Australian law.

For investors who meet that bar and want targeted exposure to companies like SpaceX, OpenAI, Anthropic, or Anduril, start with an introduction call to discuss what's currently available.

ASX-listed funds with private holdings

A small number of listed investment trusts hold pre-IPO positions and trade on the ASX like ordinary securities.

The Pengana Private Equity Trust (ASX: PE1) is the most prominent. Managed by GCM Grosvenor, PE1 holds over 550 private companies globally, with SpaceX currently at roughly 14% of the underlying portfolio. The trust pays a target distribution yield of 4% per annum on NAV and has been listed since 2019.

The catch with PE1 is the discount to NAV. As a closed-ended trust, its unit price can trade well below the value of its holdings. As of early 2026, that discount sat around 30%. Whether that represents a buying opportunity or a structural feature of the vehicle depends on your view of when (and whether) the discount will narrow.

Regal Funds Management also operates a pre-IPO fund targeting Australian companies, with quarterly applications and semi-annual redemptions. It invests across listed and unlisted microcaps, pre-IPO placements, and IPOs, and is open to wholesale and sophisticated investors.

US-listed ETFs with private company exposure

Several US-listed ETFs now hold pre-IPO companies directly or through SPV structures. Australian investors can access them via platforms like Stake, Interactive Brokers, or CMC Markets.

The ERShares Private-Public Crossover ETF (XOVR) manages close to US$1.5 billion with SpaceX as its largest position. The KraneShares AI and Technology ETF (AGIX) holds both SpaceX and Anthropic within a broader AI portfolio. The Tema Space Innovators ETF (NASA), launched in March 2026, allocates roughly 15% to SpaceX through an SPV.

Daily liquidity is the obvious appeal. But US regulations cap illiquid holdings at 15% of an ETF's net assets. If redemptions shrink the fund's public holdings, the private allocation can breach that limit, creating regulatory and concentration risk. Private holdings are also marked periodically rather than priced in real time, so the NAV won't always reflect current secondary-market activity.

Eligibility: who can invest in pre-IPO companies in Australia?

Australian securities law restricts pre-IPO access to wholesale and sophisticated investors under the Corporations Act 2001. The rationale is straightforward: private market investments carry illiquidity risk, limited disclosure, and the real possibility of total capital loss. The regulatory framework reserves these opportunities for investors with enough financial capacity to absorb those outcomes.

Two primary pathways exist.

The wealth test (Section 761G)

Under section 761G(7)(c), a qualified accountant must certify that you hold net assets of at least A$2.5 million, or gross income of at least A$250,000 per annum in each of the past two financial years. Net assets can include the family home, superannuation, and investments. The certificate is valid for two years.

The experience test (Section 761GA)

Under section 761GA, a financial services licensee can determine that you have enough experience in financial products to evaluate the opportunity without retail-level protections. This pathway is more subjective. The licensee bears the burden of proving the assessment was reasonable if it's later challenged.

What wholesale classification means in practice

Once classified as wholesale, issuers are not required to give you a Product Disclosure Statement, prospectus, or target market determination. You lose access to the Australian Financial Complaints Authority (AFCA) for most dispute resolution. The due diligence responsibility shifts squarely to you.

Worth understanding before you proceed. The access is genuine, and so is the accountability that comes with it.

If you're not sure where you sit, book an introduction call with NonPublic. We'll walk through it.

What SPVs are and why they matter

If you invest through a platform like NonPublic, your investment will be structured through an SPV.

An SPV is a legal entity created for a single purpose: to hold shares in a specific private company on behalf of a group of investors. Rather than each investor acquiring shares individually (which most private companies won't facilitate), the SPV pools capital and acquires the shares as one entity on the company's cap table.

From the company's perspective, they see one shareholder. From yours, you have economic exposure proportional to your contribution.

A few details worth paying attention to. SPV managers typically charge a management fee and/or carried interest (a share of profits above a threshold). Your shares sit within the SPV, not directly in your name. And the SPV's governing documents define your rights across different exit scenarios: IPO, acquisition, secondary sale, or dissolution.

SPVs are well-established structures in global private markets. They work. But read the offering documents before you commit, and make sure you understand the fee mechanics and exit terms.

The risks, honestly

Pre-IPO investing carries risks that operate differently from anything in listed markets. I'd rather be upfront about them than bury them in a disclaimer.

Illiquidity sits at the centre of everything. You cannot sell when you feel like it. There is no order book, no market maker, no liquidity on demand. Your capital stays committed until something happens: an IPO, an acquisition, a secondary opportunity. If the company delays its listing by two years, your money is locked for two years. Plan accordingly.

Valuations between funding rounds are estimates. Private companies aren't required to report financial results publicly. The "value" of your holding between funding events is a best-guess number. It can shift dramatically when a new round reprices the company, in either direction.

Companies fail, even at late stages. WeWork reached a US$47 billion valuation before its attempted IPO revealed structural problems. FTX was valued at US$32 billion before collapsing. A high private-market valuation and prominent backers do not guarantee survival.

Dilution erodes your position over time. Every new funding round can dilute existing shareholders. If the company raises at a lower valuation than your entry (a "down round"), your investment loses value on paper before any exit occurs.

You know less than insiders do. As a secondary-market buyer, your information set is smaller than what founders, board members, and lead investors are working with. The quality of your diligence process determines whether you're making a decision or making a guess.

These risks aren't reasons to avoid pre-IPO investing. They're reasons to size your positions conservatively, diversify across multiple opportunities where possible, and never allocate capital you can't afford to have locked up for years.

How to evaluate a specific opportunity

When a pre-IPO deal lands in front of you, here's what to interrogate.

The business itself. Revenue trajectory. Margin profile. Competitive position. Management quality. Customer concentration. Whether the company is profitable or burning cash, and at what rate. A great company at a reasonable price is the only foundation worth building on.

The price you're paying. What multiple of revenue or earnings does the entry valuation imply? How does it compare to the most recent primary round? To comparable public companies? SpaceX at US$1.75 trillion trades at roughly 110 times 2025 revenue. You need an explicit view on whether that growth rate justifies that multiple.

The structure. Management fees, carried interest, transfer restrictions, SPV governance, exit waterfall. Two SPVs offering the same underlying shares can produce meaningfully different net returns depending on fee structure and terms.

The liquidity path. Has the company filed for an IPO? Engaged underwriters? Set a timeline? A company with a confidential S-1 filing and a roadshow date is a different bet from one where management has mentioned listing "eventually."

Your portfolio context. Pre-IPO positions should be satellite allocations, not core holdings. The illiquidity and binary outcome profile warrant cautious sizing regardless of your conviction level.

The current opportunity window

We are in an unusual moment for pre-IPO investing. SpaceX has filed confidentially with the SEC and is targeting a mid-2026 listing. OpenAI is expected to IPO by late 2026 or early 2027. Anthropic is widely anticipated to follow. Anduril continues to scale rapidly within the defence technology sector. Databricks, Stripe, and others sit in the pipeline behind them.

The global IPO market raised US$171.8 billion in 2025, a 39% increase year on year, and 2026 is shaping up to be even more active. Multiple sources describe the emerging IPO pipeline as the strongest since 2021, driven by AI-aligned companies and improving macroeconomic conditions.

For Australian wholesale investors, the window between now and these anticipated listings represents a finite period of access. Once these companies go public, the pre-IPO pathway closes. The shares trade on an exchange. Everyone has access. And the entry price reflects public-market demand, not private-market negotiation.

NonPublic provides Australian wholesale and sophisticated investors with curated access to pre-IPO companies including SpaceX, OpenAI, Anthropic, and Anduril through SPV structures. To explore what's currently available, book an introduction call with our team.

This content is general in nature and does not constitute financial advice. Investing in private markets involves significant risk, including the potential loss of your entire investment. Past performance of private companies is not indicative of future results. You should obtain independent financial advice before making any investment decision.